Danaher Corporation $DHR Shares Sold by BI Asset Management Fondsmaeglerselskab A S

Key Points

• BI Asset Management Fondsmaeglerselskab A S reduced its stake in Danaher Corporation by 13.9%, holding 32,016 shares valued at approximately $6.56 million after selling 5,183 shares.
• Analysts have varied price targets for Danaher, with HSBC lowering their target from $270 to $240, while Barclays increased their target from $215 to $225 and rated the stock as "overweight."
• Danaher reported a quarterly EPS of $1.80, exceeding analyst expectations, and projected an EPS guidance of 7.700-7.800 for FY 2025.

BI Asset Management Fondsmaeglerselskab A S decreased its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 13.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 32,016 shares of the conglomerate's stock after selling 5,183 shares during the period. BI Asset Management Fondsmaeglerselskab A S's holdings in Danaher were worth $6,563,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in shares of Danaher by 0.4% in the first quarter. Vanguard Group Inc. now owns 59,981,088 shares of the conglomerate's stock valued at $12,296,123,000 after buying an additional 230,966 shares in the last quarter. Bank of New York Mellon Corp raised its holdings in Danaher by 2.3% during the first quarter. Bank of New York Mellon Corp now owns 8,783,485 shares of the conglomerate's stock worth $1,800,614,000 after purchasing an additional 194,466 shares during the last quarter. Northern Trust Corp raised its holdings in Danaher by 14.3% during the fourth quarter. Northern Trust Corp now owns 7,934,991 shares of the conglomerate's stock worth $1,821,477,000 after purchasing an additional 992,594 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Danaher by 11.4% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,677,032 shares of the conglomerate's stock worth $1,303,163,000 after purchasing an additional 579,046 shares during the last quarter. Finally, Invesco Ltd. raised its holdings in Danaher by 44.5% during the first quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate's stock worth $965,259,000 after purchasing an additional 1,450,703 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on DHR shares. HSBC reduced their price objective on Danaher from $270.00 to $240.00 in a report on Friday, April 25th. Evercore ISI cut their price target on Danaher from $230.00 to $226.00 and set an "outperform" rating for the company in a report on Tuesday, July 8th. Barclays reissued an "overweight" rating and issued a $225.00 price target (up from $215.00) on shares of Danaher in a report on Tuesday, June 24th. JPMorgan Chase & Co. cut their price target on Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a report on Tuesday, April 22nd. Finally, Royal Bank Of Canada reissued an "outperform" rating and issued a $250.00 price target on shares of Danaher in a report on Wednesday, April 23rd. Seventeen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $247.61.

Danaher Trading Up 1.5%

Shares of DHR opened at $212.2350 on Wednesday. The company has a market capitalization of $151.97 billion, a P/E ratio of 45.16, a P/E/G ratio of 2.92 and a beta of 0.73. Danaher Corporation has a one year low of $171.00 and a one year high of $279.90. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The stock has a 50-day moving average price of $200.33 and a 200 day moving average price of $199.54.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The firm had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.Danaher's revenue for the quarter was up 3.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Sell-side analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.